| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 34 |
| 1 | CAPECITABINE | 23 |
| 2 | OXALIPLATIN | 23 |
| 3 | FUROSEMIDE | 14 |
| 4 | PEGFILGRASTIM | 14 |
| 5 | DENOSUMAB | 13 |
| 6 | FLUOROURACIL | 13 |
| 7 | FLUOROURACIL CREAM, 0.5% | 13 |
| 8 | LANSOPRAZOLE | 13 |
| 9 | OXYCODONE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACELLULAR TISSUE ENGINEERED VESSEL | 4 | 0.3636 |
| 1 | PEGFILGRASTIM | 14 | 0.0012 |
| 2 | VECURONIUM BROMIDE | 1 | 0.0007 |
| 3 | LEVOLEUCOVORIN INJECTION | 2 | 0.0007 |
| 4 | CASPOFUNGIN ACETATE | 1 | 0.0006 |
| 5 | SCOPOLAMINE | 2 | 0.0005 |
| 6 | LEVOLEUCOVORIN | 2 | 0.0005 |
| 7 | ROPIVACAINE HYDROCHLORIDE | 1 | 0.0004 |
| 8 | ALBUMIN HUMAN | 2 | 0.0004 |
| 9 | ATROPINE SULFATE INJECTION | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 36 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 36 |
| 2 | Platinum-based Drug [EPC] | 33 |
| 3 | Proton Pump Inhibitor [EPC] | 15 |
| 4 | Leukocyte Growth Factor [EPC] | 14 |
| 5 | Loop Diuretic [EPC] | 14 |
| 6 | Opioid Agonist [EPC] | 14 |
| 7 | RANK Ligand Inhibitor [EPC] | 13 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 9 | Corticosteroid [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 36 | 0.0002 |
| 1 | Anticholinergic [EPC] | 3 | 0.0002 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 36 | 0.0001 |
| 3 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 4 | Epidermal Growth Factor Receptor Antagonist [EPC] | 6 | 0.0001 |
| 5 | Platinum-based Drug [EPC] | 33 | 0.0001 |
| 6 | Leukocyte Growth Factor [EPC] | 14 | 0.0001 |
| 7 | RANK Ligand Inhibitor [EPC] | 13 | 0.0001 |
| 8 | Opioid Agonist [EPC] | 14 | 0.0001 |
| 9 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |